论文部分内容阅读
目的综合分析阿替普酶与银杏叶滴丸联合治疗在急性脑梗死治疗中的应用效果。方法 46例急性脑梗死患者,随机分为实验组与对照组,每组23例。对照组给予阿替普酶治疗,实验组在对照组的基础上给予银杏叶滴丸治疗。比较两组的治疗效果。结果实验组不良反应发生率低于对照组,差异具有统计学意义(P<0.05);治疗后7 h、10 d、20 d,实验组美国国立卫生院神经功能缺损评分(NIHSS)均优于对照组,差异具有统计学意义(P<0.05)。结论阿替普酶与银杏叶滴丸联合治疗在急性脑梗死治疗中的应用效果比较显著。
Objective To analyze the combined effect of alteplase and ginkgo leaf pills in the treatment of acute cerebral infarction. Methods 46 cases of acute cerebral infarction were randomly divided into experimental group and control group, 23 cases in each group. The control group was treated with alteplase, and the experimental group was treated with Ginkgo biloba dropping pills on the basis of the control group. Compare the treatment effect of two groups. Results The incidence of adverse reactions in the experimental group was lower than that in the control group (P <0.05). At 7, 10 and 20 days after treatment, NIHSS in the experimental group were all better than those in the control group Control group, the difference was statistically significant (P <0.05). Conclusion The combination therapy of alteplase and gingko leaf dropping pills has obvious effect in the treatment of acute cerebral infarction.